| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |